au.\*:("MANNING, Richard")
Results 1 to 8 of 8
Selection :
Pharmaceutical Risk-Sharing AgreementsCOOK, Joseph P; VERNON, John A; MANNING, Richard et al.PharmacoEconomics (Auckland). 2008, Vol 26, Num 7, pp 551-556, issn 1170-7690, 6 p.Article
Antithrombin Nagasaki (Ser 116 to Pro) : a rare antithrombin variant with abnormal heparin binding presenting during pregnancyO'DONNELL, James S; HINKSON, Larry; MCCARTHY, Andrew et al.Blood coagulation & fibrinolysis. 2006, Vol 17, Num 3, pp 217-220, issn 0957-5235, 4 p.Article
Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarctionMERCURI, Eugenio; COWAN, Frances; GUPTE, Girish et al.Pediatrics (Evanston). 2001, Vol 107, Num 6, pp 1400-1404, issn 0031-4005Article
Beta-adrenergic receptor polymorphisms in patients with elevated factor VIII levels with venous thrombosisO'DONNELL, James; MANNING, Richard A; LAFFAN, Michael A et al.British journal of haematology. 2003, Vol 123, Num 1, pp 139-141, issn 0007-1048, 3 p.Article
Monitoring heparin anticoagulation in the acute phase responseUPRICHARD, James; MANNING, Richard A; LAFFAN, Michael A et al.British journal of haematology. 2010, Vol 149, Num 4, pp 613-619, issn 0007-1048, 7 p.Article
Should Laparoscopic Cholecystectomy be Practiced in the Developing World?: The Experience of the First Training Program in AfghanistanMANNING, Richard G; ABDUL QAYOUME AZIZ.Annals of surgery. 2009, Vol 249, Num 5, pp 794-798, issn 0003-4932, 5 p.Article
Low-density lipoprotein receptor-related protein polymorphisms in patients with elevated factor VIII coagulant activity and venous thrombosisCUNNINGHAM, Nicholas; LAFFAN, Michael A; MANNING, Richard A et al.Blood coagulation & fibrinolysis. 2005, Vol 16, Num 7, pp 465-468, issn 0957-5235, 4 p.Article
Genotype at the Secretor blood group locus is a determinant of plasma von Willebrand factor levelO'DONNELL, James; BOULTON, Frank E; MANNING, Richard A et al.British journal of haematology. 2002, Vol 116, Num 2, pp 350-356, issn 0007-1048Article